You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ipilimumab

Showing 51 - 75 of 914
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastroenteropancreatic Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor Trial in Cleveland (TQ Formula (black

Not yet recruiting
  • Gastroenteropancreatic Neuroendocrine Tumor
  • Gastroenteropancreatic Neuroendocrine Neoplasm
  • TQ Formula (black seed oil capsules)
  • +2 more
  • Cleveland, Ohio
    University hospitals Seidman Cancer Center, Case Comprehensive C
Aug 12, 2022

NSCLC Trial in Tampa, Chapel Hill, Durham (Thoracic Radiotherapy, Platinum Based Chemotherapy, Ipilimumab)

Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Thoracic Radiotherapy
  • +3 more
  • Tampa, Florida
  • +2 more
Sep 30, 2022

Metastatic Renal Cell Carcinoma Trial in Cleveland (Nivolumab, Ipilimumab)

Active, not recruiting
  • Metastatic Renal Cell Carcinoma
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jan 25, 2023

Brain Metastases, Renal Cell Carcinoma Trial in Houston (Nivolumab, Ipilimumab, Cabozantinib)

Not yet recruiting
  • Brain Metastases
  • Renal Cell Carcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Jul 9, 2022

Mesothelioma Trial run by the National Cancer Institute (NCI) (LMB-100, ipilimumab)

Recruiting
  • Mesothelioma
  • LMB-100
  • ipilimumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 6, 2022

MGMT-unmethylated Glioblastoma (GBM), GBM Trial in New York (Nivolumab, Ipilimumab, Radiation Therapy (RT))

Completed
Has Results
  • MGMT-unmethylated Glioblastoma (GBM)
  • GBM
  • New York, New York
    New York University School of Medicine
Jun 30, 2022

Larynx, Lip, Oral Cavity and Pharynx Trial in Philadelphia (Nivolumab, Ipilimumab, Simultaneous-Integrated Boost

Completed
  • Larynx
  • Lip, Oral Cavity and Pharynx
  • Nivolumab
  • +3 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Nov 16, 2022

Gastrointestinal Stromal Tumor Trial in Los Angeles (Ipilimumab, Laboratory Biomarker Analysis, Nivolumab)

Completed
  • Gastrointestinal Stromal Tumor
  • Ipilimumab
  • +2 more
  • Los Angeles, California
    Rachel Andes
Aug 15, 2022

HCC - Hepatocellular Carcinoma, Metastatic Cancer, Metastatic Tumor Trial in France (Ipilimumab Injection, Atezolizumab

Not yet recruiting
  • HCC - Hepatocellular Carcinoma
  • +2 more
  • Ipilimumab Injection
  • +2 more
  • Créteil, France
  • +7 more
Dec 27, 2022

Hematopoietic and Lymphoid Cell Tumor, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in

Not yet recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 10, 2022

Kidney Medullary Carcinoma, Loss of INI 1 Protein Expression, Stage III Renal Cell Cancer AJCC v8 Trial in Houston (Ipilimumab,

Active, not recruiting
  • Kidney Medullary Carcinoma
  • +3 more
  • Ipilimumab
  • Nivolumab
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Non Small Cell Lung Cancer, Solid Tumor Trial in Jette, Brussel (Avelumab, Ipilimumab 5 MG/ML, Pembrolizumab 100 MG in 4 ML

Recruiting
  • Non Small Cell Lung Cancer
  • Solid Tumor
  • Jette, Brussels, Belgium
  • +1 more
Sep 9, 2022

Metastatic Malignant Tumor in the Liver, Metastatic Uveal Melanoma, Stage IV Uveal Melanoma AJCC v7 Trial in Philadelphia

Active, not recruiting
  • Metastatic Malignant Neoplasm in the Liver
  • +2 more
  • Ipilimumab
  • +2 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Aug 15, 2022

Oncology, Infusion Reaction Trial (Nivolumab, Pembrolizumab, Ipilimumab)

Not yet recruiting
  • Oncology
  • Infusion Reaction
  • (no location specified)
Sep 8, 2023

Melanoma, Ocular Melanoma Trial in United States (Nivolumab, Ipilimumab)

Active, not recruiting
  • Melanoma
  • Ocular Melanoma
  • San Francisco, California
  • +5 more
Aug 31, 2022

Nivolumab, Ipilimumab, and Chemotherapy in Non-small Cell Lung

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
    • Athens, Greece
      Local Institution - 0001
    Oct 26, 2022

    Renal Cell Carcinoma Trial in Canada, United States (Nivolumab, Ipilimumab)

    Terminated
    Has Results
    • Renal Cell Carcinoma
    • Nivolumab
    • Ipilimumab
    • Saint Louis, Missouri
    • +11 more
    Dec 15, 2022

    Neuroblastoma, Pediatric Solid Tumor Trial in Boston (procedure, biological, drug)

    Recruiting
    • Neuroblastoma
    • Pediatric Solid Tumor
    • Tissue collection
    • +3 more
    • Boston, Massachusetts
    • +1 more
    Oct 17, 2022

    Active, not recruiting
    • Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
    • +8 more
    • Cetuximab
    • +3 more
    • Pittsburgh, Pennsylvania
      University of Pittsburgh Cancer Institute (UPCI)
    Jan 26, 2023

    Refractory Cutaneous Melanoma Trial in Portland (Ipilimumab, Nivolumab, Cabozantinib)

    Recruiting
    • Refractory Cutaneous Melanoma
    • Ipilimumab
    • +2 more
    • Portland, Oregon
      Providence Portland Medical Center
    Jun 8, 2022

    Renal Cell Carcinoma Trial in Switzerland (nivolumab, ipilimumab)

    Active, not recruiting
    • Renal Cell Carcinoma
    • Aarau, Switzerland
    • +13 more
    Oct 17, 2022

    Advanced Melanoma Trial in United States (FLX475, Ipilimumab)

    Recruiting
    • Advanced Melanoma
    • Los Angeles, California
    • +3 more
    Jun 10, 2022

    Metastatic Malignant Tumor in the Brain, Stage IV NSCLC AJCC v7 Trial in Houston (procedure, biological, other, radiation)

    Recruiting
    • Metastatic Malignant Neoplasm in the Brain
    • Stage IV Non-Small Cell Lung Cancer AJCC v7
    • Cognitive Assessment
    • +5 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 12, 2022

    Melanoma Trial in United States (CAVATAK, Ipilimumab)

    Completed
    • Melanoma
    • CAVATAK
    • Ipilimumab
    • Duarte, California
    • +10 more
    Jan 12, 2023

    Lung Cancer Metastatic Trial in Durham (Nivolumab, Ipilimumab, Evolocumab)

    Recruiting
    • Lung Cancer Metastatic
    • Durham, North Carolina
      Duke Univ. Medical Center
    May 16, 2022